Response to Re ‘Endovascular Treatment of Chronic and Acute on Chronic Mesenteric Ischaemia: Results From a National Cohort of 245 Cases’

Altintas, Ümit; Sillesen, Henrik; Eiberg, Jonas

doi:10.1016/j.ejvs.2021.04.024

Cited by 2 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Altinas et al [89] conducted a study involving 245 patients who underwent endovascular intervention, categorizing them into two groups: those with chronic mesenteric ischemia (CMI) and those with acute-on-chronic mesenteric ischemia (AoCMI). In terms of one-year and three-year survival estimates, the CMI group exhibited rates of 85% and 74%, respectively.…”

Section: Endovascular Revascularization: Balloon-expandable Covered S...mentioning

confidence: 99%

Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review

Xhepa,

Vanzulli,

Sciacqua

et al. 2023

JCM

View full text Add to dashboard Cite

Chronic mesenteric ischemia (CMI) arises from the inability to achieve adequate intestinal blood flow after meals, leading to an imbalance between oxygen and metabolite supply and demand. The true incidence of CMI remains uncertain. However, the occurrence of mesenteric artery occlusive disease (MAOD) is relatively common among the elderly population. Delays in diagnosing CMI can often be attributed to several factors, including the variability in patient symptoms and the range of potential causes for chronic abdominal pain with weight loss. Mikkelson pioneered the introduction of a surgical treatment for occlusive lesions of the superior mesenteric artery (SMA) in 1957. The inaugural performance of endovascular revascularization (ER) for visceral vessels took place in 1980. The literature has documented two types of endovascular revascularization (ER) methods: percutaneous transluminal angioplasty (PTA) and primary stenting (PMAS). Despite the limited quality of available evidence, the consensus among experts is strongly in favor of PMAS over PTA alone for the treatment of atherosclerotic mesenteric artery stenosis. There are several key areas of focus for chronic mesenteric ischemia (CMI) treatment. Randomized controlled trials comparing different stent types, such as covered stents versus bare metal stents, are needed to evaluate efficacy, patency rates, and long-term outcomes in CMI patients.

show abstract

Section: Endovascular Revascularization: Balloon-expandable Covered S...mentioning

confidence: 99%

Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review

Xhepa,

Vanzulli,

Sciacqua

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review

Xhepa,

Vanzulli,

Sciacqua

et al. 2023

Preprint

View full text Add to dashboard Cite

Chronic Mesenteric Ischemia (CMI) arises from the inability to achieve adequate intestinal blood flow after meals, leading to an imbalance between oxygen and metabolite supply and demand. The true incidence of CMI remains uncertain. However, the occurrence of mesenteric artery occlusive disease (MAOD) is relatively common among the elderly population. Delays in diagnosing CMI can often be attributed to several factors, including the variability of patient symptoms, the range of potential causes for chronic abdominal pain with weight loss. Mikkelson pioneered the introduc-tion of a surgical treatment for occlusive lesions of the superior mesenteric artery (SMA) in 1957. The inaugural performance of endovascular revascularization (ER) for visceral vessels took place in 1980. The literature has documented two types of endovascular revascularization (ER) methods: percutaneous transluminal angioplasty (PTA) and primary stenting (PMAS). Despite the limited quality of available evidence, the consensus among experts is strongly in favor of PMAS over PTA alone for the treatment of atherosclerotic mesenteric artery stenosis. There are several key areas of focus for chronic mesenteric ischemia (CMI) treatment. Randomized controlled trials comparing different stent types, such as covered stents versus bare metal stents, are needed to evaluate effi-cacy, patency rates, and long-term outcomes in CMI patients.

show abstract

Response to Re ‘Endovascular Treatment of Chronic and Acute on Chronic Mesenteric Ischaemia: Results From a National Cohort of 245 Cases’

Cited by 2 publications

References 4 publications

Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review

Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review

Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review

Contact Info

Product

Resources

About